Ausgabe 5/2011
LOX-1: A Novel Target for Treatment of Cardiovascular Diseases
Inhalt (13 Artikel)
Oxidized Low Density Lipoproteins-Do We Know Enough About Them?
Xueting Jiang, Zhaohui Yang, Aluganti Narasimhulu Chandrakala, Dawn Pressley, Sampath Parthasarathy
Open Access
The Discovery of LOX-1, its Ligands and Clinical Significance
Ryo Yoshimoto, Yoshiko Fujita, Akemi Kakino, Shin Iwamoto, Tomohide Takaya, Tatsuya Sawamura
LOX-1 and Angiotensin Receptors, and Their Interplay
Xianwei Wang, M. Ian Phillips, Jawahar L. Mehta
LOX-1: A Critical Player in the Genesis and Progression of Myocardial Ischemia
Jingjun Lü, Jawahar L. Mehta
Novel Concepts in the Genesis of Hypertension: Role of LOX-1
Ping Luo, Meiling Yan, Edward D. Frohlich, Jawahar L. Mehta, Changping Hu
LOX-1, Oxidative Stress and Inflammation: A Novel Mechanism for Diabetic Cardiovascular Complications
Meiling Yan, Jawahar L. Mehta, Weifang Zhang, Changping Hu
Angiogenesis is a Link Between Atherosclerosis and Tumorigenesis: Role of LOX-1
Junlin Jiang, Meiling Yan, Jawahar L. Mehta, Changping Hu
Do Atherosclerosis and Obesity-Associated Susceptibility to Cancer Share Causative Link to oxLDL and LOX-1?
Magomed Khaidakov, Jawahar L. Mehta
LOX-1/LOXIN: The Yin/Yang of Atheroscleorosis
Ruggiero Mango, Irene Marta Predazzi, Francesco Romeo, Giuseppe Novelli
LOX-1: A New Target for Therapy for Cardiovascular Diseases
Jawahar L. Mehta, Magomed Khaidakov, Paul L. Hermonat, Sona Mitra, Xianwei Wang, Guiseppe Novelli, Tatsuya Sawamura